Dupilumab improves signs, symptoms, and quality of life in adolescents with moderate to severe atopic dermatitis

被引：0

作者：

Eichenfield, Lawrence F.

Silverberg, Jonathan I. ^{[1
]}

Gadkari, Abhijit ^{[2
]}

Guillemin, Isabelle ^{[3
]}

Chen, Zhen ^{[3
]}

Bansal, Ashish ^{[2
]}

Eckert, Laurent ^{[3
]}

Rosner, Karli ^{[4
]}

机构：

[1] George Washington Univ, Sch Med, Washington, DC 20052 USA

[2] Regeneron Pharmaceut, Tarrytown, NY USA

[3] Sanofi, Paris, France

[4] Sanofi Genzyme, Cambridge, MA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

15013

引用

页码：AB26 / AB26

页数：1

共 50 条

[41] Severe atopic dermatitis and dupilumab
Bernardo, Wanderley
Bernardo, Luca Silveira
Baroni, Juliana Hegedus
Simoes, Ricardo dos Santos
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (01): : 2 - 6
[42] Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
Giavina-Bianchi, Mara
Giavina-Bianchi, Pedro
EINSTEIN-SAO PAULO, 2021, 19 : eRC6064
[43] Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis
Miniotti, Marco
Lazzarin, Giulia
Ortoncelli, Michela
Mastorino, Luca
Ribero, Simone
Leombruni, Paolo
DERMATOLOGIC THERAPY, 2022, 35 (05)
[44] Dupilumab treatment restores skin barrier function and improves clinical and patient reported outcomes in adults and adolescents with moderate to severe atopic dermatitis
Bissonnette, Robert
Agueusop, Inoncent
Praestgaard, Amy
Levit, Noah A.
Rossi, Ana B.
Zhang, Annie
ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 560 - 560
[45] Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study
Pagan, Angel D.
David, Eden
Ungar, Benjamin
Ghalili, Sabrina
He, Helen
Guttman-Yassky, Emma
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (09): : 2378 - 2385
[46] Real-life efficacy and safety of upadacitinib in adolescents with moderate-to-severe atopic dermatitis unresponsive to dupilumab: A case series
Patruno, Cataldo
Fabbrocini, Gabriella
Potestio, Luca
Genco, Lucia
Napolitano, Maddalena
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (07) : E901 - E903
[47] Dupilumab treatment restores skin barrier function and improves clinical and patient reported outcomes in adults and adolescents with moderate to severe atopic dermatitis
Bissonnette, Robert
Leung, Donald Y. M.
Bologna, Gabriel
Levit, Noah A.
Rossi, Ana B.
Zhang, Annie
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB160 - AB160
[48] Dupilumab treatment for up to 5 years improves clinical signs across all anatomical regions in adults with moderate-to-severe atopic dermatitis
Beck, L. A.
Bissonnette, R.
Deleuran, M.
Nakahara, T.
Galus, R.
Chen, Z.
Avetisova, E.
Dubost-Brama, A.
Shabbir, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S364 - S364
[49] COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Ungar, Benjamin
Glickman, Jacob W.
Golant, Alexandra K.
Dubin, Celina
Marushchak, Olga
Gontzes, Alyssa
Mikhaylov, Daniela
Singer, Giselle K.
Baum, Danielle
Wei, Nancy
Sanin, Antonio
Gruenstein, Diana
Lebwohl, Mark G.
Pavel, Ana B.
Guttman-Yassky, Emma
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 134 - 142
[50] DUPILUMAB PROVIDES EARLY AND SUSTAINED IMPROVEMENT IN SLEEP IN ADOLESCENTS AND ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Beck, Lisa A.
Simpson, Eric L.
de Bruin-Weller, Marjolein
Wollenberg, Andreas
Kataoka, Yoko
Barbarot, Sebastien
Bansal, Ashish
Chen, Zhen
Levit, Noah A.
Chao, Jingdong
Prescilla, Randy
ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 54 - 54

← 1 2 3 4 5 →